MedPath

ADAPT: A Clinical Trial of Adaptive Treatment for Early Smoking Cessation Relapse - UAB

Daily cigarette smokers may qualify for a UAB research study involving online screening, 8 contacts over 6 months, and trying varenicline or nicotine patches/lozenges. Compensation available. More info at https://redcap.musc.edu/surveys/?s=8JWFT9XFY3FYR7Y3.


Reference News

ADAPT: A Clinical Trial of Adaptive Treatment for Early Smoking Cessation Relapse - UAB

Daily cigarette smokers may qualify for a UAB research study involving online screening, 8 contacts over 6 months, and trying varenicline or nicotine patches/lozenges. Compensation available. More info at https://redcap.musc.edu/surveys/?s=8JWFT9XFY3FYR7Y3.

© Copyright 2025. All Rights Reserved by MedPath